Editorial Comment on "Impact of cytoreductive nephrectomy prior to combination therapy of ipilimumab plus nivolumab in metastatic renal cell carcinoma"

Int J Urol. 2023 Sep;30(9):752-753. doi: 10.1111/iju.15210. Epub 2023 May 23.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Carcinoma, Renal Cell* / drug therapy
  • Carcinoma, Renal Cell* / surgery
  • Cytoreduction Surgical Procedures
  • Humans
  • Ipilimumab / therapeutic use
  • Kidney Neoplasms* / drug therapy
  • Kidney Neoplasms* / surgery
  • Nephrectomy
  • Nivolumab / therapeutic use

Substances

  • Nivolumab
  • Ipilimumab